Articles
Personalised Approaches to Improving the Effect of Anti-platelet Agents: Where Do We Stand?
Citation:
European Cardiology Review 2019;14(3):179–80
Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
Citation:
European Cardiology Review 2019;14(3):201
Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
Citation:
European Cardiology Review 2019;14(3):139–40
Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
Citation:
European Cardiology Review 2019;14(3):159–60
Deciphering the Riddles in Nutrition and Cardiovascular Disease
Citation:
European Cardiology Review 2019;14(3):141–50
Meditation and Cardiovascular Health: What is the Link?
Citation:
European Cardiology Review 2019;14(3):161–4
Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
Citation:
European Cardiology Review 2019;14(3):165–8
Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease
Citation:
European Cardiology Review 2019;14(3):187–90